KLK3 and posterior cortical atrophy: Recurrence may occur in up to half of patients initially diagnosed with high-risk PCa (≥T3 a N0 M0 disease, prostate-specific antigen (PSA)>20 ng/mL and/or International Society of Urological Pathology grade≥4).2, 4